Literature DB >> 19531900

Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients.

Mitsuru Abe1, Takeshi Kimura, Takeshi Morimoto, Yutaka Furukawa, Toru Kita.   

Abstract

BACKGROUND: Contrast-induced nephropathy (CIN) is the third leading cause of all hospital-acquired renal insufficiency, accounting for 10%, and is associated with increased long-term mortality. The incidence of and risk factors for CIN after cardiac catheterization in Japanese patients are, however, unknown at present. METHODS AND
RESULTS: The 1,157 consecutive patients who underwent cardiac catheterization at Kyoto University Hospital from January 2003 to December 2004 were retrospectively examined. The incidence of CIN defined as an absolute increase in serum creatinine (SCr) > or =0.5 mg/dl, a relative > or =25% increase in SCr, and either an absolute or relative increase after cardiac catheterization were 4.0%, 13.8%, and 13.9%, respectively. Multivariate logistic models revealed that preexisting renal insufficiency and the use of high-volume contrast were independently associated with an absolute increase in SCr > or =0.5 mg/dl. Female gender, underweight, and high-volume contrast usage were independently associated with a relative > or =25% increase and either an absolute or relative increase in SCr.
CONCLUSIONS: Although the incidence of and risk factors for CIN after cardiac catheterization varied in the study population according to the definition of CIN, careful attention should be paid to patients who have risk factors identified by each definition of CIN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531900     DOI: 10.1253/circj.cj-08-0784

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  9 in total

1.  Questionnaires for examinations using iodinated contrast media and their grades of recommendation: Japan Radiological Society/Japanese College of Radiology Joint Committee on Contrast Media Safety.

Authors:  Hiromitsu Hayashi; Yoshifumi Narumi; Ryo Takagi; Yasuo Takehara; Yasuaki Arai; Ryohei Kuwatsuru; Yukunori Korogi; Hideharu Sugimoto; Yoshito Tsushima; Katsumi Hayakawa; Kunihiko Fukuda; Shozo Tamura; Sachio Kuribayashi
Journal:  Jpn J Radiol       Date:  2011-10-19       Impact factor: 2.374

2.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-08       Impact factor: 2.801

3.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Jpn J Radiol       Date:  2013-08       Impact factor: 2.374

4.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

5.  Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine.

Authors:  Takeji Saitoh; Hiroshi Satoh; Mamoru Nobuhara; Masashi Machii; Takamitsu Tanaka; Hayato Ohtani; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

6.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

7.  Optimizing contrast medium injection protocol individually with body weight for high-pitch prospective ECG-triggering coronary CT angiography.

Authors:  Jie Liu; Jianbo Gao; Runze Wu; Yonggao Zhang; Lili Hu; Ping Hou
Journal:  Int J Cardiovasc Imaging       Date:  2013-01-04       Impact factor: 2.357

8.  Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats.

Authors:  Binghui Zhao; Qing Zhao; Junhui Li; Tao Xing; Feng Wang; Niansong Wang
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

9.  Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis.

Authors:  Feng Wang; Guangyuan Zhang; Yang Zhou; Dingkun Gui; Junhui Li; Tao Xing; Niansong Wang
Journal:  Oxid Med Cell Longev       Date:  2014-10-21       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.